Spiramycin

Kathryn Dzintars, Pharm.D., BCPS, Paul A. Pham, Pharm.D.
Spiramycin is a topic covered in the Johns Hopkins ABX Guide.

To view the entire topic, please or .

Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:

-- The first section of this topic is shown below --

INDICATIONS

FDA

  • Spiramycin: not commercially available in the US.
    • May be obtained as below (see Adult Dosing)
  • Indicated for treatment of primary toxoplasmosis in pregnant women in order to prevent congenital toxoplasmosis (IgM titer needs to be confirmed by Dr. J. Remington’s lab 650-326-8120).

NON-FDA APPROVED USES

-- To view the remaining sections of this topic, please or --

INDICATIONS

FDA

  • Spiramycin: not commercially available in the US.
    • May be obtained as below (see Adult Dosing)
  • Indicated for treatment of primary toxoplasmosis in pregnant women in order to prevent congenital toxoplasmosis (IgM titer needs to be confirmed by Dr. J. Remington’s lab 650-326-8120).

NON-FDA APPROVED USES

There's more to see -- the rest of this entry is available only to subscribers.

Last updated: October 24, 2016